TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Austar Lifesciences Ltd. ( (HK:6118) ) has shared an update.
Austar Lifesciences Ltd. has announced a board meeting scheduled for August 26, 2025, to review and approve the unaudited interim results for the first half of the year and consider the declaration of an interim dividend. This meeting is significant as it could impact the company’s financial strategy and shareholder returns, potentially influencing its market position and investor confidence.
More about Austar Lifesciences Ltd.
Austar Lifesciences Ltd. operates in the life sciences industry, focusing on providing innovative solutions and services. The company is involved in the development and distribution of products and services that support the life sciences sector.
Average Trading Volume: 1,408,733
Technical Sentiment Signal: Buy
Current Market Cap: HK$722.7M
See more insights into 6118 stock on TipRanks’ Stock Analysis page.

